Market Overview:
The global newborn screening devices market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of birth defects and the growing demand for early diagnosis and treatment. In addition, the rising awareness about newborn screening tests among parents is also contributing to the growth of this market. On the basis of type, the global newborn screening devices market can be segmented into dry blood spot test, hearing screen test, and critical congenital heart diseases (CCHD) test. The dry blood spot test segment is expected to account for a major share of this market in 2018 owing to its low cost and easy availability. On the basis of application, hospitals are expected to account for a major share of this market in 2018 owing to their large patient base and growing demand for early diagnosis and treatment options.
Product Definition:
Newborn screening devices are used to test for certain medical conditions in newborns. The conditions that are screened for vary from state to state, but typically include genetic diseases, hearing loss, and metabolic disorders. Early detection of these conditions can allow for early treatment and improved outcomes. Newborn screening is important because it can identify medical problems in babies before they cause serious health complications.
Dry Blood Spot Test:
Dry blood spot test is a non-invasive procedure used to detect hemoglobinopathies in infants and children. It utilizes a small sample of dried blood obtained from the heel or an earlobe of the child. The dried blood spot is analyzed for various hemoglobin variants using specialized equipment.
Hearing Screen Test:
Hearing Screen Test (HST) is a non-invasive test used to evaluate the hearing ability in the newborn. The test helps screen for possible hearing disorders in neonates. This device uses an electronic audiometer that measures the response of a baby’s ear to sound frequencies.
The HST is performed on full term infants within 24 hours of their birth.
Application Insights:
The global newborn screening devices market is segmented by application into hospitals and clinics. Hospitals held the largest share in 2017 owing to the availability of advanced healthcare facilities, experienced staff, and well-established infrastructure at this end-point for diagnosis. However, a growing number of hospital based laboratories across developing countries may hamper growth.
Clinic based testing is anticipated to witness significant growth over the forecast period due to increasing awareness about early detection of congenital heart diseases (CHD). This can be attributed to rising incidence rates of CHD coupled with improved treatment options available for these diseases. For instance, since March 2018 until now more than 20 babies have been diagnosed with transposition of the great arteries through echocardiography conducted by The National Institute Of Cardiovascular Diseases (NICHD), Paediatric Cardiology Department at Children¢â‚¬â„¢s Hospital Los Angeles (CHLA).
Regional Analysis:
North America dominated the global newborn screening devices market in 2017. This can be attributed to favorable reimbursement policies, increasing prevalence of congenital disorders, and government initiatives. For instance, according to the March of Dimes Birth Defects Prevention Campaign in 2014; every year around 15 million infants are born worldwide with heart defects, approximately 3 million are born with neural tube defects (spina bifida and anencephaly) and 1 infant is born with cri du chat syndrome (trisomy 13). Thus these government initiatives focus on early detection of these conditions which is expected to drive the demand for NGS testing devices over the forecast period.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to improving healthcare infrastructure coupled with rising awareness among people about newborn screening programs especially in rural areas as well as remote islands where there is a high population density.
Growth Factors:
- Increasing incidence of newborn diseases: The global incidence of newborn diseases is increasing due to various factors such as changing lifestyle, environmental pollution, and others. This is expected to drive the demand for newborn screening devices over the forecast period.
- Growing awareness about benefits of early diagnosis: There is a growing awareness among healthcare professionals and parents about the benefits of early diagnosis through newborn screening devices. This is expected to propel the growth of this market during the forecast period.
- Technological advancements in screening devices: The technological advancements in screening devices are helping healthcare professionals detect various disorders at an early stage in infants’ life cycle thereby improving their prognosis and quality of life outcomes significantly. This is anticipated to boost demand for these products over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Newborn Screening Devices Market Research Report
By Type
Dry Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) Test
By Application
Hospitals, Clnic
By Companies
Ab Sciex, Perkinelmer, Waters, Natus Medical Incorporated, Masimo Corporation, Agilent Technologies, Bio-Rad Laboratories, Medtronic, GE Healthcare, Trivitron Healthcare, Ab Sciex
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
176
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Newborn Screening Devices Market Report Segments:
The global Newborn Screening Devices market is segmented on the basis of:
Types
Dry Blood Spot Test, Hearing Screen Test, Critical Congenital Heart Diseases (CCHD) Test
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clnic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ab Sciex
- Perkinelmer
- Waters
- Natus Medical Incorporated
- Masimo Corporation
- Agilent Technologies
- Bio-Rad Laboratories
- Medtronic
- GE Healthcare
- Trivitron Healthcare
- Ab Sciex
Highlights of The Newborn Screening Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dry Blood Spot Test
- Hearing Screen Test
- Critical Congenital Heart Diseases (CCHD) Test
- By Application:
- Hospitals
- Clnic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Newborn Screening Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Newborn screening devices are medical devices that can be used to detect certain health problems in newborns. These devices include blood pressure cuffs, heart rate monitors, and oxygen sensors.
Some of the key players operating in the newborn screening devices market are Ab Sciex, Perkinelmer, Waters, Natus Medical Incorporated, Masimo Corporation, Agilent Technologies, Bio-Rad Laboratories, Medtronic, GE Healthcare, Trivitron Healthcare, Ab Sciex.
The newborn screening devices market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Newborn Screening Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Newborn Screening Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Newborn Screening Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Newborn Screening Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Newborn Screening Devices Market Size & Forecast, 2020-2028
4.5.1 Newborn Screening Devices Market Size and Y-o-Y Growth
4.5.2 Newborn Screening Devices Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Dry Blood Spot Test
5.2.2 Hearing Screen Test
5.2.3 Critical Congenital Heart Diseases (CCHD) Test
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clnic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Newborn Screening Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Newborn Screening Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Dry Blood Spot Test
9.6.2 Hearing Screen Test
9.6.3 Critical Congenital Heart Diseases (CCHD) Test
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clnic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Dry Blood Spot Test
10.6.2 Hearing Screen Test
10.6.3 Critical Congenital Heart Diseases (CCHD) Test
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clnic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Dry Blood Spot Test
11.6.2 Hearing Screen Test
11.6.3 Critical Congenital Heart Diseases (CCHD) Test
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clnic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Dry Blood Spot Test
12.6.2 Hearing Screen Test
12.6.3 Critical Congenital Heart Diseases (CCHD) Test
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clnic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Dry Blood Spot Test
13.6.2 Hearing Screen Test
13.6.3 Critical Congenital Heart Diseases (CCHD) Test
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clnic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Newborn Screening Devices Market: Competitive Dashboard
14.2 Global Newborn Screening Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ab Sciex
14.3.2 Perkinelmer
14.3.3 Waters
14.3.4 Natus Medical Incorporated
14.3.5 Masimo Corporation
14.3.6 Agilent Technologies
14.3.7 Bio-Rad Laboratories
14.3.8 Medtronic
14.3.9 GE Healthcare
14.3.10 Trivitron Healthcare
14.3.11 Ab Sciex
